The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Serum Uric Acid and Cardiovascular Events in Successfully Treated Hypertensive Patients
Open accessAbstract
Abstract —To determine whether pretreatment and/or in-treatment serum uric acid (SUA) is independently and specifically associated with cardiovascular events in hypertensive patients, we examined the 20-year experience of 7978 mild-to-moderate hypertensive participants in a systematic worksite treatment program. Clinical evaluation and treatment were protocol-directed. SUA was measured at entry and annually thereafter. Subjects were stratified according to gender-specific quartile of baseline SUA. Blood pressures at entry and in-treatment were, respectively, 152.5/95.6 and 138.9/85.4 mm Hg. SUA was normally distributed with a mean of 0.399±0.0893 and 0.321±0.0833 mmol/L for men and women, respectively. Subjects with highest SUA were heavier, had greater evidence of cardiovascular disease (CVD), higher systolic blood pressure, higher creatinine, more frequent diuretic use, and lower prevalence of diabetes. During an average follow-up of 6.6 years (52 751 patient-years), 548 CVD events (183 mortal) and 116 non-CVD events occurred. In bivariate analysis, the association of SUA to CVD was more robust in nonwhites than whites and in patients at low versus high CVD risk. In multivariate analysis, CVD incidence was significantly associated with SUA with a hazard ratio of 1.22 (95% confidence interval 1.11 to 1.35), controlling for other known cardiovascular risk factors, including serum creatinine, body mass index, and diuretic use. Despite blood pressure control, SUA levels increased during treatment and were significantly and directly associated with CVD events, independently of diuretic use and other cardiovascular risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
(1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410020010002 · Cited by 1,608
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465
Towards the physiological function of uric acid
Becker, B. F. (1993) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(93)90143-i · Cited by 833
Zavaroni, I., Bonora, E., Pagliara, M., Dall'Aglio, E., Luchetti, L., Buonanno, G., Bonati, P. A., Bergonzani, M., Gnudi, L., Passeri, M., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201105 · Cited by 771
Relation of Serum Uric Acid to Mortality and Ischemic Heart Disease
Freedman, D. S., Williamson, D. F., Gunter, E. W., & Byers, T. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117479 · Cited by 443
Lehto, S., Niskanen, L., Rönnemaa, T., & Laakso, M. (1998) · Stroke · doi:10.1161/01.str.29.3.635 · Cited by 411
HYPERURICEMIA AS A RISK FACTOR OF CORONARY HEART DISEASE: THE FRAMINGHAM STUDY
BRAND, F. N., MCGEE, D. L., KANNEL, W. B., STOKES, J., & CASTELLI, W. P. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113972 · Cited by 390
Role of Cytokines in Inducing Hyperlipidemia
Feingold, K. R., & Grunfeld, C. (1992) · Diabetes · doi:10.2337/diab.41.2.s97 · Cited by 378
Suarna, C., Dean, R. T., May, J., & Stocker, R. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.10.1616 · Cited by 355
SERUM URIC ACID IN RELATION TO AGE AND PHYSIQUE IN HEALTH AND IN CORONARY HEART DISEASE
GERTLER, M. M., GARN, S. M., & LEVINE, S. A. (1951) · Annals of Internal Medicine · doi:10.7326/0003-4819-34-6-1421 · Cited by 351
Uric acid metabolism and tubular sodium handling. Results from a population-based study
Cappuccio, F. P. (1993) · JAMA · doi:10.1001/jama.270.3.354 · Cited by 233
Lee, J. W., Sparrow, D., Vokonas, P., Landsberg, L., & Weiss, S. T. (1995) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117634 · Cited by 221
Detection and Treatment of Hypertension at the Work Site
Alderman, M. H., & Schoenbaum, E. E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197507102930203 · Cited by 177
Self-citationUric Acid Metabolism and Tubular Sodium Handling: Results From a Population-Based Study
Cappuccio, F. P. (1993) · JAMA · doi:10.1001/jama.1993.03510030078038 · Cited by 158
Uric acid as an independent risk factor in the treatment of hypertension
Ward, H. J. (1998) · The Lancet · doi:10.1016/s0140-6736(05)60816-1 · Cited by 153
Relation of components of insulin resistance syndrome to coronary disease risk
Després, J., & Marette, A. (1994) · Current Opinion in Lipidology · doi:10.1097/00041433-199408000-00006 · Cited by 143
Alderman, M. H., Cohen, H. W., & Madhavan, S. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816060-00007 · Cited by 82
Self-citationFrohlich, E. D. (1993) · JAMA · doi:10.1001/jama.1993.03510030102044 · Cited by 60
Cited by
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
Johnson, R. J., Kang, D.-H., Feig, D., Kivlighn, S., Kanellis, J., Watanabe, S., Tuttle, K. R., Rodriguez-Iturbe, B., Herrera-Acosta, J., & Mazzali, M. (2003) · Hypertension · doi:10.1161/01.hyp.0000069700.62727.c5 · Cited by 1,361
Self-citationElevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Self-citationPacher, P., Nivorozhkin, A., & Szabó, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.6 · Cited by 1,218
Johnson, R. J., Segal, M. S., Sautin, Y., Nakagawa, T., Feig, D. I., Kang, D.-H., Gersch, M. S., Benner, S., & Sánchez-Lozada, L. G. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.4.899 · Cited by 1,075
Metadata
- Authors
- Alderman, M. H., Cohen, H., Madhavan, S., & Kivlighn, S.
- Venue
- Hypertension
- Published
- 1999-07
- Volume
- 34
- Issue
- 1
- Pages
- 144-150
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W1997145262
- Cited by
- 441
- References
- 22
- FWCI
- 12.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.